The European Medicines Agency (EMA) has updated its post-authorization guidance on how extensions of marketing authorizations and type II variations may impact orphan-designated medicines. The updates ...
Dublin, April 13, 2026 (GLOBE NEWSWIRE)-- The "Variations to Marketing Authorisations (June 2nd - June 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will be ...